- Status Quo of Chronic Liver Diseases, Including Hepatocellular Carcinoma, in Mongolia
-
Jazag A, Puntsagdulam N, Chinburen
- KMID: 1776536
- Korean J Intern Med.
- 2012 Jun;27(2):121-127.
- doi: 10.3904/kjim.2012.27.2.121
Because Mongolia has much higher liver disease burden than any other regions of the world, it is necessary to provide information on real-time situation of chronic liver disease in Mongolia.... -
- CITED
-
- Close
- SHARE
-
- Close
- Cholangiocarcinoma: Current Knowledge and New Developments
-
Blechacz B
- KMID: 2412151
- Gut Liver.
- 2017 Jan;11(1):13-26.
- doi: 10.5009/gnl15568
Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is more common in Asia, its incidence in Europe and North America has significantly increased in recent decades. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Type and cause of liver disease in Korea: single-center experience, 2005-2010
-
Lee SS, Byoun YS, Jeong SH, Kim YM, Gil H, Min BY, Seong MH, Jang ES, Kim JW
- KMID: 1392911
- Clin Mol Hepatol.
- 2012 Sep;18(3):309-315.
- doi: 10.3350/cmh.2012.18.3.309
BACKGROUND/AIMS: The aim of this study was to describe the types and causes of liver disease in patients from a single community hospital in Korea between April 2005 and May... -
- CITED
-
- Close
- SHARE
-
- Close
- A study of the awareness of chronic liver diseases among Korean adults
-
Jun DW, Cho YK, Sohn JH, Lee CH, Kim SH, Eun JR
- KMID: 1015568
- Korean J Hepatol.
- 2011 Jun;17(2):99-105.
- doi: 10.3350/kjhep.2011.17.2.99
BACKGROUND/AIMS: Chronic liver disease is closely associated with lifestyle, and public enlightenment of the lifestyle factors is important in reducing prevalence of chronic liver disease. The KASL (Korean Association for... -
- CITED
-
- Close
- SHARE
-
- Close
- Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
-
Moon JC, Kim SH, Kim IH, Lee CH, Kim SW, Lee SO, Lee ST, Kim DG
- KMID: 2155648
- Gut Liver.
- 2015 May;9(3):395-404.
- doi: 10.5009/gnl14170
BACKGROUND/AIMS: We investigated factors associated with the disease progression and development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients during long-term oral nucleos(t)ide analog (NA) therapy. METHODS: This retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma
-
Kwon JH, Ahn KS, Moon YH, Park JY, Wang HJ, Choi KY, Kim G, Joh JW, Lee KG, Kang KJ
- KMID: 2344149
- J Korean Med Sci.
- 2015 Sep;30(9):1253-1259.
- doi: 10.3346/jkms.2015.30.9.1253
Despite a low risk of liver failure and preserved liver function, non-cirrhotic hepatocellular carcinoma (HCC) has a poor prognosis. In the current study, we evaluated an active regulator of SIRT1... -
- CITED
-
- Close
- SHARE
-
- Close
